Immuron (IMRN) Receivables - Net (2016 - 2025)
Immuron (IMRN) posted quarterly Receivables - Net of $18883.7 for Q3 2025, up 36.09% year-on-year from $13875.7 in Q3 2024, and down 98.61% on a QoQ basis from $1.4 million in Q2 2025.
Immuron (IMRN) Receivables - Net (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Receivables - Net for 10 consecutive years, with $18883.7 the latest figure, recorded in Q3 2025.
- Quarterly Receivables - Net rose 36.09% year-over-year to $18883.7 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18883.7 (up 36.09% YoY) and the FY2025 annual result came in at $18883.7, up 36.09% from the prior year.
- Receivables - Net declined to $18883.7 in Q3 2025 per IMRN's latest filing, from $1.4 million in the prior quarter.
- Over the last five years, Receivables - Net for IMRN reached as high as $1.6 million in Q4 2024 and fell as low as $3950.5 in Q4 2023.
- A 5-year average of $426418.8 and a median of $265585.3 in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2023 — Receivables - Net tumbled 99.16% — and 2024, when it surged 39968.15%.
- Year by year, Receivables - Net stood at $236378.3 in 2021, then jumped by 98.05% to $468153.5 in 2022, then slumped by 99.16% to $3950.5 in 2023, then jumped by 39968.15% to $1.6 million in 2024, then tumbled by 98.81% to $18883.7 in 2025.
- According to Business Quant data, Receivables - Net over the past three periods registered $18883.7, $1.4 million, and $1.6 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 18,883.70 |
| Sep 2, 2025 | 18,883.70 |
| Jun 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 9, 2024 | 13,875.73 |
| Sep 9, 2024 | 13,875.73 |
| Jun 30, 2024 | 979,938.29 |
| Jun 30, 2024 | 979,938.29 |
| Dec 31, 2023 | 3,950.49 |
| Dec 31, 2023 | 3,950.49 |
| Sep 28, 2023 | 294,792.30 |
| Sep 28, 2023 | 294,792.30 |
| Aug 30, 2023 | 4,174.20 |
| Aug 30, 2023 | 4,174.20 |
| Jun 30, 2023 | 46,821.00 |
| Jun 30, 2023 | 46,821.00 |
| Dec 31, 2022 | 468,153.51 |
| Dec 31, 2022 | 468,153.51 |